Avian Influenza

Safety issues may hamper production of bird flu vaccine

Published in Vaccine Weekly, March 1st, 2006

Making vaccines against avian influenza, commonly called bird flu, is difficult and many problems need to be overcome before production begins on a vaccine for the disease, according to an article in the February 2006 issue of Microbiology Today, the quarterly magazine of the Society for General Microbiology.

There are worldwide anxieties about the spread of influenza and mutation of the H5N1 virus that causes bird flu to acquire the ability to transmit easily from person to person.

"Since many experts believe we are on the verge of an influenza pandemic, it is important to understand what are the options for protecting the population against...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2006-03-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry